LATEST
Thu, Sep 3, 2026
Loading weather...
Markets

Here's Why Ionis Pharmaceuticals' Steep Sell-off Was Overdone

Key PointsIonis experienced a double-whammy in July with two clinical setbacks....

Key PointsIonis experienced a double-whammy in July with two clinical setbacks.

SOURCE: Nasdaq
ORIGINAL REPORT: Click here
DHALLO EDITORIAL STATUS: Aggregated & reviewed
Have feedback on this article?Report error or suggestion

Read More from Markets

1500% dividend stock alert! Check amount per share, record date, payment timeline and performance

GOCL Corporation announces an astonishing 1500% dividend, launching investor ent...

Read Article »

Uber faces backlash over ‘Parcel Mini 3W’ service, use of passenger autos for goods delivery in Bengaluru: Report

Uber's new 'Parcel Mini 3W' service in Bengaluru faces criticism for using passe...

Read Article »

16% jump in share price of this firm after ₹100 cr order Tata Motors PV | Do you own?

Autoline Industries shares surged nearly 16% in intraday trade on Thursday, Sept...

Read Article »
Return to Front Page

5 minutes. The news that matters.

Get the most important stories of the day, without having to browse hundreds of articles.